Vaccine

Scott Dryden-Peterson

Botswana’s cautionary tale of the co-epidemic of HIV and cervical cancer

October 13, 2016

HIV infection increases mortality in African women with cervical cancer

“Botswana was the first country in Africa to provide comprehensive HIV treatment to its citizens and has one of the most effective antiretroviral treatment programs globally,” Scott Dryden-Peterson, MD, instructor of medicine at Harvard Medical School and associate physician at Brigham and Women’s Hospital, told HemOnc Today. “As such, trends in Botswana are indicative of what will happen in other heavily HIV affected countries that also now have good access to HIV treatment.… Read more about Botswana’s cautionary tale of the co-epidemic of HIV and cervical cancer

BIDMC Research Team Presents Exciting New Results with Experimental HIV Vaccine in Monkeys

BIDMC Research Team Presents Exciting New Results with Experimental HIV Vaccine in Monkeys

July 13, 2015

An experimental HIV vaccine developed with Dr. Dan Barouch (HU CFAR Executive Committee member and Director of the HU CFAR Program in HIV Vaccines), his team of researchers at BIDMC, and Johnson & Johnson has protected 6 out of 12 monkeys against HIV. The exciting results, published in “Science,” are leading researchers to begin the first human trials with 400 volunteers in the U.S., Thailand, South Africa, Rwanda, and Uganda. Results are expected by next year, and the trials will ascertain whether or not the vaccine is safe and also creates an immune response. These will be the first… Read more about BIDMC Research Team Presents Exciting New Results with Experimental HIV Vaccine in Monkeys